September 3, 2025 S&P 500 futures are up 0.4% after Tuesday’s pullback, with tech (especially semis), capital goods, financials, transports, and chemicals lagging yesterday while retail, biotech/pharma, managed care, and precious metals miners outperformed. Treasuries remain weaker, with yields up ~2 bp and the 30Y just under 5%. Dollar index -0.1%, gold +0.4%, Bitcoin -0.2%, […]
ETFsector.com Daily Trading Outlook Read More »
August 4, 2025 S&P futures are up 0.7% in early trading, rebounding from Friday’s selloff that left all major indexes down over 2% for the week (Russell 2000 -4%). Overnight, Asian markets were mixed (Japan down, Hong Kong and Korea up ~1%), while Europe is up over 1%. Treasuries are weaker, with yields up ~3
ETFsector.com Daily Trading Outlook Read More »
February 27, 2025 S&P futures +0.5% after a mixed Wednesday where S&P and Nasdaq snapped their four-day losing streaks. Semis led, staples lagged. Asian markets mixed (Japan, China higher; Hong Kong weaker), while Europe down 0.6%. Treasuries lower, though rates still down for the week. Dollar +0.2%, Gold -0.9%, Bitcoin +2.4%, WTI crude +0.9%. Key
ETFsector.com Daily Trading Outlook Read More »
Wells Fargo Company MN reduced its investment in United Therapeutics Co. by 13.4% during the fourth quarter as reported in its Form 13F filing with the SEC.
United Therapeutics Co. had its shares sold by Wells Fargo & Company MN. Read More »
United Therapeutics is a company that is seen as exciting but faces a major challenge.
StockNews.com raised United Therapeutics shares’ rating from buy to strong-buy in a report released on Thursday. Several other analysts also made upgrades and downgrades to the company’s stock.
United Therapeutics’ rating on StockNews.com has been elevated to a “Strong-Buy.” Read More »
Stay updated with the latests analysis and insights fromm etfsector.com